NEW YORK, April 12 – A German court ruled Thursday that Thermo-Finnigan's GCQ and LCQ ion traps infringe upon Bruker Daltonics’ European patent for ion trap mass spectrometry and ordered Thermo-Finnigan to pay Bruker damages and court costs, Bruker said.

Bruker sued Bremen, Germany-based Thermo Finnigan and its affiliates in Dusseldorf District Court for patent infringement of its patent EP 0336 990, which relates to ion trap technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.